Vibration Response Imaging – lung saver of the future
61-year-old Israeli pediatrician Igal Kushnir and his company Deep Breeze has developed a new technology called Vibration Response Imaging (VRI). What it does is measure energy generated in the lungs, analyze it, and then display an image of the person’s lungs in one go.
This new technology has been found to accurately diagnose lung conditions such as asthma, pneumonia, and lung tumors.
What makes this method so amazing is the fact that it uses no radiation. It works by analyzing acoustic vibrations resonating or sounds from a person’s lungs, much like a stethoscope. The lung vibrations are then fed to a computer, where it’s displayed as images.
Deep Breeze was given approval by the US Food and Drug Administration last July 23 to begin marketing a VRI device in the U.S. Other countries such as Israel, the European Union, and South Korea have also cleared the product for distribution.
While the technology is still expensive at an average price of US$ 40,000 to US$ 50,000 per unit. Deep Breeze is working to create cheaper versions of it which will go for as low as US$ 10,000 per machine. This is big news in the medical community as this device will undoubtedly save a lot of lives by removing a lot of the guesswork usually experienced in using the common stethoscope.
Via Business Week
61-year-old Israeli pediatrician Igal Kushnir and his company Deep Breeze has developed a new technology called Vibration Response Imaging (VRI). What it does is measure energy generated in the lungs, analyze it, and then display an image of the person’s lungs in one go.
This new technology has been found to accurately diagnose lung conditions such as asthma, pneumonia, and lung tumors.
What makes this method so amazing is the fact that it uses no radiation. It works by analyzing acoustic vibrations resonating or sounds from a person’s lungs, much like a stethoscope. The lung vibrations are then fed to a computer, where it’s displayed as images.
Deep Breeze was given approval by the US Food and Drug Administration last July 23 to begin marketing a VRI device in the U.S. Other countries such as Israel, the European Union, and South Korea have also cleared the product for distribution.
While the technology is still expensive at an average price of US$ 40,000 to US$ 50,000 per unit. Deep Breeze is working to create cheaper versions of it which will go for as low as US$ 10,000 per machine. This is big news in the medical community as this device will undoubtedly save a lot of lives by removing a lot of the guesswork usually experienced in using the common stethoscope.
Via Business Week
About The Author
